l-carnitine tmao koeth 2013 nature medicine Meat-metabolizing bacteria in atherosclerosis γ-Butyrobetaine Is a Proatherogenic Intermediate
Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect l carnitine tmao nature medicine 2013 koeth Gut microbiota metabolism of l carnitine and cardiovascular risk Dietary allicin reduces transformation of Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism TMAO: how gut microbiota contributes to heart failure Translational Research
Pay in 4 interest-free payments of $5.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




